cropper
update
Local Women Entrepreneurs
update
  • Home
  • Categories
    • local marketing
    • community engagement
    • business growth
    • sales strategies
    • customer relationships
    • networking tips
    • digital promotion
    • grassroots tactics
    • market reach
    • brand awareness
    • marketing tips
    • reputation
    • Health
February 09.2026
2 Minutes Read

ImmunityBio's New IL-15 Superagonist Anktiva: A Game-Changer for Bladder Cancer Patients

Anktiva medication packaging from ImmunityBio

ImmunityBio’s Breakthrough Approval Marks a New Dawn for Bladder Cancer Treatment

In a significant leap for cancer treatment, ImmunityBio has announced the FDA approval of Anktiva, an innovative IL-15 superagonist designed for patients with non-muscle invasive bladder cancer (NMIBC) who are unresponsive to the typical Bacillus Calmette-Guérin (BCG) therapy. This marks not just a new medication, but a beacon of hope for patients battling an often aggressive illness.

Understanding Anktiva’s Impact

According to the American Cancer Society, bladder cancer affects approximately 83,190 new patients each year, leading to numerous distressing health outcomes, particularly in the older demographic. With an impressive complete response rate observed in clinical trials, Anktiva offers a compelling alternative for those who have historically faced disheartening prognosis and high rates of recurrence. With clinical data showing that 62% of participants maintained remission for over 47 months, Anktiva could fundamentally transform the standard of care for NMIBC patients.

The Unique Mechanism Behind Anktiva

Dr. Patrick Soon-Shiong, ImmunityBio's Global Chief Scientific and Medical Officer, remarked on the "triangle offense" approach of Anktiva, emphasizing its ability to activate not only CD8+ T cells and natural killer cells but also CD4+ T helper cells. This multidimensional strategy represents an evolution in immunotherapy, resembling the biology of dendritic cells and promising a more robust immune response against cancerous cells.

The Road to Approval

After overcoming initial setbacks in the approval process, ImmunityBio's renewed focus led to the successful resubmission of the Biologics License Application (BLA), enabling Anktiva’s launch. This journey highlights the resilience common in the biotech community, underlining the importance of persistence in advancing innovative healthcare solutions.

Looking Forward: What This Means for Patients

As Anktiva is prepared for market release, it holds the promise of changing lives by offering a new, effective treatment option. For communities and healthcare providers, the arrival of Anktiva is not just a scientific achievement but a crucial turning point in how we can support and restore the health of those affected by bladder cancer.

community engagement

11 Views

Write A Comment

*
*
Please complete the captcha to submit your comment.
Related Posts All Posts
04.30.2026

Navigating Success: Why Many Tech Startups Avoid Fundraising

Update Unveiling the Reality of BootstrappingIn the vibrant tech landscape of Southern California, a notable number of startups are navigating the choppy waters of business without the lifeline of external funding. Among these businesses is Convoso, a software-as-a-service company founded by brothers Nima and Bobby Hakimi in 2006. Their journey exemplifies a quiet yet resilient path taken by over half of the tech companies in the region. According to PitchBook, while 47% of tech companies receive some form of backing, 53% like Convoso thrive on their own, often proving that success doesn't always require a venture capital boost.The Strength of Longevity Over Quick GrowthConvoso's story is a testament to bootstrapping—a method that, despite its challenges, often results in sustainable business practices. Unlike their venture-backed counterparts aiming for rapid scaling and high valuations, companies like Convoso, which focus on solid cash flow and incremental growth, tend to exhibit greater longevity in the ever-evolving tech ecosystem. Nima Hakimi himself acknowledges, "Being bootstrapped is tough. You have to make more tradeoffs," a sentiment that resonates with many founders striving for stability over the volatile promises of quick investment returns.A Shifting Landscape of Venture CapitalThe venture funding landscape has dramatically transformed in Los Angeles over the years. Once dominated by limited options for capital, the region now boasts a plethora of investors keen to support tech startups. Brian Garrett from Crosscut Ventures reflects this change, noting that many successful early tech companies in L.A. raised hardly any venture funding at all, building their trajectories through profits and reinvestment. This presents a compelling point: while venture capital opens doors for some, it isn’t a universal solution for all business models. "Less than 10% of businesses are actually right for venture dollars," Garrett states, highlighting the importance of a tailored approach to funding.Finding the Community in Business SuccessIn an era where community support and local economies are increasingly emphasized, the stories of businesses like Convoso and their bootstrapped origins are crucial. These companies not only contribute to their immediate economies but also foster a sense of community—creating connections that extend beyond mere transactions. As small business owners navigate this path, they echo a shared vision of resilience through mutual support and grassroots initiatives, illustrating that the journey to success can be both enriching and deeply connected to the local fabric.Join the Conversation!As this article illustrates, the tech scene in Los Angeles is rich with stories of perseverance and creativity. For those interested in understanding the diverse paths businesses take to succeed, it's crucial to engage with local narratives. These stories not only inspire but also provide valuable insights into the fabric of the community. Let's celebrate the local heroes who embody resilience and foster connections in our neighborhoods.

04.30.2026

How Bruin Biometrics Aims to Tackle a $27 Billion Issue in Healthcare

Update Innovative Solutions in Healthcare: Tackling BedsoresIn an alarming twist, healthcare costs related to bedsores, also known as pressure ulcers, have ballooned to an estimated $27 billion annually. This staggering figure paints a vivid picture of the burden placed on healthcare providers, patients, and their families. Bruin Biometrics, a pioneer spin-off from UCLA, has stepped into this urgent arena with innovative technology designed to change the trajectory of care for those at risk of developing these debilitating wounds.How the ProVizio Scanner WorksImagine a world where you could detect the first signs of a pressure ulcer before it develops. The ProVizio scanner by Bruin Biometrics makes that a reality. Caregivers can monitor key areas of the skin by gently applying this cutting-edge device to locations like the heel or base of the spine. If the moisture level exceeds a set threshold, it acts as an alert system allowing for immediate preventative measures—such as repositioning the patient or using specialized mattresses that redistribute pressure.Why This Technology MattersAs our aging population continues to grow, the implications of this technology become increasingly significant. The National Pressure Injury Advisory Panel reports that millions of people suffer from pressure injuries each year with an unsettling 60,000 fatalities attributed to related complications. With the potential to detect issues early, ProVizio is transforming patient care, allowing healthcare providers to act swiftly and effectively. It’s not just about reducing costs; it’s about saving lives.A Bright Future for Patient CareThe journey to implement such innovations is crucial in reshaping the future of healthcare. As Emily Brooks, a community-focused journalist, highlights, grassroots efforts like Bruin Biometrics demonstrate how local initiatives can bring about transformative impacts in medicine. This story of ingenuity offers hope and a heartfelt reminder of the caring driven behind medical advancements.This technology could herald a new era not only for hospitals but also for home-care settings, ensuring that vulnerable patients receive the compassionate, timely care they deserve. As medical technology evolves, one can only imagine the bright future ahead for patient well-being. As we witness this change, it reaffirms the vital link between innovation and community health.

04.28.2026

Brentwood Apartments Sold: A New Benchmark for Property Investment

Update Brentwood's Multifamily Market Shines with recent Sales Los Angeles’ thriving Brentwood neighborhood is making waves in the real estate world with the recent sale of two multifamily properties totaling more than $46 million. These two complexes, boasting a combined 61 units, are not just a significant investment for their new owners, but they also set a new standard for the price per unit in this high-demand area. What Makes Brentwood Special? According to industry experts like Rabbie Banafsheha from Marcus & Millichap, Brentwood is one of the most coveted and supply-constrained markets in Los Angeles. With only a handful of multifamily transactions occurring within the year, these sales exemplify the competitive landscape. “Brentwood stands apart as a high-barrier, supply-constrained market with limited new development and strong long-term rental demand,” adds Tony Azzi, representing the seller. A Record-Breaking Sale Process What’s remarkable about this deal is the quick turnaround. The properties received over 10 offers and closed in under 60 days, demonstrating the intense interest in this unique market. The success of these transactions was built on strategic execution, creating competitive tension and exceeding client expectations. A Bright Future for Brentwood Apartments Reflecting on the ongoing trends surrounding multi-family housing during 2026, Tony Solomon, another senior managing director at Marcus & Millichap, emphasizes the selective nature of Los Angeles’ multifamily market. He notes that despite heightened financing costs, Brentwood’s appeal as a community with low vacancy rates continues to attract investors. Join the Conversation As Brentwood's real estate landscape evolves, there’s a lot to celebrate about this vibrant neighborhood. Whether you’re a homeowner, investor, or curious community member, staying informed about market changes is key to navigating this dynamic future.

Terms of Service

Privacy Policy

Core Modal Title

Sorry, no results found

You Might Find These Articles Interesting

T
Please Check Your Email
We Will Be Following Up Shortly
*
*
*